Funds and ETFs Sinphar Pharmaceutical Co.,Ltd.

Equities

1734

TW0001734002

Pharmaceuticals

End-of-day quote Taiwan S.E. 18:00:00 2024-05-30 EDT 5-day change 1st Jan Change
36.5 TWD +0.83% Intraday chart for Sinphar Pharmaceutical Co.,Ltd. +0.41% +7.51%

ETFs positioned on Sinphar Pharmaceutical Co.,Ltd.

Name Weight AuM 1st Jan change Investor Rating
0.00% 112 M€ +4.61% -
Sinphar Pharmaceutical Co., Ltd. is principally engaged in the research and development, manufacture and distribution of pharmaceuticals. The Company is also engaged in the sales of functional food products. The Company’s principal products include ointment, gel, cream, hard and soft capsules, sugar-coated tablets, film-coated tablets, suppositories, powders and granules, lozenges, soft candies, oral and topical liquid medicines, injections, dry medicated powers, functional food products, medical equipment and cosmetics. The Company mainly sells its products to hospitals, drug stores, clinics, dealers and distributors. Its primary markets are located in Taiwan and overseas countries.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 1734 Stock
  4. Funds and ETFs Sinphar Pharmaceutical Co.,Ltd.